Dear colleagues and friends,
We are pleased to announce that the 5th ReSViNET Foundation Conference “RSVVW 2019”, a global conference on novel RSV therapeutics. It will be held on 12-14 November 2019, in the beautiful capital city of Ghana, Accra, at the Mövenpick Ambassador Hotel. Ghana is one of the most peaceful countries in Africa and a tourism hub for the continent. Accra is a city full of life and excitement with a prodigious history, monuments, cultural diversity, arts and crafts, and more.
The main goal of this conference is to offer a platform where the RSV community can share and discuss the latest research focusing on prevention as well as treatment of RSV infection. We aim to bring together stakeholders involved in RSV research such as scientists, physicians, pharmaceutical companies, and representatives from FDA, PATH, WHO, EMA, NIH, and BMGF.
Researchers and physicians from around the world are invited to join the discussion and share their knowledge. Specifically, scientists and physicians from low- and middle-income countries and young researchers are encouraged to attend, and may apply to receive support. This meeting is a great forum to discuss opportunities for future international collaboration and achievements in our field.
A diverse program is being developed by the Scientific Advisory Committee which will include: burden of RSV disease and mortality, molecular virology, immunology, prevention and treatment developments, global health perspectives and RSV-related sequelae. We anticipate an exciting scientific event that will expand our knowledge of RSV.
For more details and latest updates regarding the conference please visit our website (www.resvinet.org). If you have any questions about the conference, please do not hesitate to contact us at [email protected], or [email protected]
Registration will be open in April 2019”. More information will follow.
We look forward to your participation to make this event a success!